New asthma drug TR4 passes early safety check in small trial
Symptom relief
Completed
This early-stage study tested a new drug called TR4 in 12 adults with mild-to-moderate asthma. The goal was to see if it is safe and how it affects the airways. Participants received either TR4 or a placebo, and researchers measured lung function and other health signs. The study…
Phase: PHASE1 • Sponsor: Trio Medicines Ltd. • Aim: Symptom relief
Last updated May 17, 2026 03:59 UTC